Clinical Psychopharmacology - (Postdoctoral) - Master of Science (Online)
The curriculum for the Postdoctoral Master of Science in Clinical Psychopharmacology (MSCP) degree program is modeled on the American Psychological Association (APA) recommended curriculum, adopted in 1998, set forth by the Blue Ribbon Task Force (comprised of national experts in psychopharmacology including physicians, psychiatrists, Department of Defense Demonstration Project prescribing psychologists, neuroscientists, pharmacists and nurses). In addition, the NMSU program adheres to all regulations set forth by the New Mexico Board of Psychologist Examiners and the New Mexico Board of Medical Examiners. And is designed in congruence with New Mexico state law for prescribing psychologists. The program is dynamic, changing with the field, and has been modified according to recommended revisions of the American Psychological Association in 2009, then again in 2019 (https://www.apa.org/education/grad/rxp-designation-criteria.pdf).The MSCP is an APA Designated Postdoctoral Psychopharmacology Education and Training Program. New Mexico State University is only one of three university programs in the country with said designation status.
This program includes two separate degree tracks: clinical and non-clinical.
Non-Clinical Track
The non-clinical track includes two (2) years of coursework and requires the ASPPB governed, national Psychopharmacology Examination for Psychologists (PEP).
Program of Study:
| Prefix | Title | Credits |
|---|---|---|
| RXPP 6110 | Introduction to Psychopharmacology for Psychologists I | 3 |
| RXPP 6120 | Introduction to Psychopharmacology for Psychologists II | 3 |
| RXPP 6210 | Clinical Psychopharmacology I | 3 |
| RXPP 6220 | Clinical Psychopharmacology II | 3 |
| RXPP 6230 | Clinical Psychopharmacology III | 3 |
| RXPP 6310 | Pathophysiology for Psychologists I | 3 |
| RXPP 6320 | Pathophysiology for Psychologists II | 3 |
| RXPP 6330 | Pathophysiology for Psychologists III | 3 |
| RXPP 6410 | Psychopharmacological Treatment in Special Populations I | 3 |
| RXPP 6420 | Psychopharmacological Treatment in Special Populations II | 3 |
| RXPP 6996 | Selected Topics | 3 |
| Total Credits | 33 | |
Clinical Track
The clinical track includes two (2) years of coursework (including hands-on experiential lab training in neurosciences, pathophysiology, and physical assessment), embedded supervised clinical fieldwork, and a final Capstone Examination/Project.
Program of Study:
| Prefix | Title | Credits |
|---|---|---|
| RXPP 6110 | Introduction to Psychopharmacology for Psychologists I | 3 |
| RXPP 6120 | Introduction to Psychopharmacology for Psychologists II | 3 |
| RXPP 6210 | Clinical Psychopharmacology I | 3 |
| RXPP 6220 | Clinical Psychopharmacology II | 3 |
| RXPP 6230 | Clinical Psychopharmacology III | 3 |
| RXPP 6310 | Pathophysiology for Psychologists I | 3 |
| RXPP 6320 | Pathophysiology for Psychologists II | 3 |
| RXPP 6330 | Pathophysiology for Psychologists III | 3 |
| RXPP 6410 | Psychopharmacological Treatment in Special Populations I | 3 |
| RXPP 6420 | Psychopharmacological Treatment in Special Populations II | 3 |
| RXPP 6510 | Supervised Experience in Psychopharmacology I | 3 |
| RXPP 6520 | Supervised Experience in Psychopharmacology II | 3 |
| RXPP 6996 | Selected Topics | 3 |
| Total Credits | 39 | |